Change in CEO/CFO Attendance vs. Targeted Investors Conversion Rate: United States 2019All-America Executive Team July 25, 2019 Related Articles For Members Only RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks Stephen Taub Biotech Surge Sends Averill to the Top of February’s Market Winners Stephen Taub From Informing AI to Empowering Traders, Quality Data is Non-Negotiable Sponsored by CME Group